Bills · HR 5187
IN COMMITTEE· 119TH CONGRESS
House BillHR 5187Armed Forces and National Security
To establish in the Department of Defense a program to support the expansion of domestic bioindustrial manufacturing capacity.
INTRO SEP 8· LAST ACTION SEP 8
READING
6MIN
COSPONSORS
2
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenThis bill matters because it addresses a growing concern about the United States' reliance on foreign countries for crucial manufactured goods, especially those vital for national defense and economic stability. By encouraging the domestic production of 'critical biomanufactured products,' it aims to make supply chains more resilient and less vulnerable to international disruptions like pandemics, geopolitical tensions, or trade disputes.
If this bill becomes law, it could stimulate investment, foster innovation, and create jobs within the U.S. bioindustrial sector, enhancing our ability to create everything from specialized materials for uniforms to advanced fuels or medicines. If it doesn't pass, the U.S. might continue to depend heavily on external sources for these products, potentially leaving it more exposed to supply chain weaknesses and national security risks.
KEY PROVISIONS
5AI-extractedPROVISION 01
Allows the Department of Defense (DoD) to establish a program offering competitive awards to private entities for establishing, upgrading, or retooling bioindustrial manufacturing facilities in the United States.
This provision creates the primary mechanism for the government to invest in and stimulate domestic bioindustrial production capacity.
PROVISION 02
Specifies that award decisions will consider criteria such as a technology's potential to improve domestic supply chain resilience, meet military needs, a facility's ability to be repurposed, and the geographic distribution of manufacturing sites.
These criteria ensure that funding supports strategic national interests and helps build a robust, adaptable manufacturing base across the country.
PROVISION 03
Requires recipients of awards to submit periodic reports on their progress in establishing or upgrading facilities, estimated timelines, products being manufactured, and efforts to secure agreements with the Department of Defense.
This provision ensures accountability for public funds and helps the DoD track the program's effectiveness and impact.
PROVISION 04
Mandates initial and annual reports from the Secretary of Defense to Congress detailing awards made, available funds, and how the program aligns with national security priorities.
This provides transparency and allows Congress to oversee the program's implementation and evaluate its ongoing relevance and impact.
PROVISION 05
Includes a 'sunset' clause, meaning the program will terminate 10 years after the bill becomes law, though the President can extend it if national economic and security needs require.
This ensures the program is not permanent without re-evaluation and allows for flexibility if it remains critical.
SPONSORSHIP
1 + 2
D· California
YRS IN OFFICE
9
BILLS LED
50
COSPONSOR BREAKDOWNBIPARTISAN · 0%
DEM 2 REP 0 IND 0
ACTION TIMELINE
2 EVENTSSEP 8
Introduced in House
SEP 8
Referred to the House Committee on Armed Services.
BILL INFO
TypeHouse Bill
NumberHR 5187
Congress119th
StatusIn Committee
IntroducedSep 8, 2025
Last actionSep 8, 2025
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · ARMED SERVICES COMMITTEE · INTRODUCED SEP 8, 2025
House BillHR 5187Armed Forces and National Security
To establish in the Department of Defense a program to support the expansion of domestic bioindustrial manufacturing capacity.
INTRODUCED SEP 8, 2025· LAST ACTION SEP 8, 2025
PASSAGE CHANCES
—%
READING
6 min
COSPONSORS
2
COMPLEXITY
Moderate
